REZOLUTE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
REZOLUTE, INC. (RZLT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.51 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-09-24
- REZOLUTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 260.00K shares, a 63.12% decline year-over-year.
- REZOLUTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 25.00K shares, a 98.64% decline year-over-year.
- REZOLUTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 1.48M shares, a 221.96% increase year-over-year.
- REZOLUTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 740.00K shares, a 208.33% increase year-over-year.
- REZOLUTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2026 was 2.51M shares, a 22.80% decline from fiscal 2025.
- REZOLUTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 3.25M shares, a 22.90% increase from fiscal 2024.
- REZOLUTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.64M shares, a 256.96% increase from fiscal 2023.
- REZOLUTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 740.00K shares, a 90.00% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 260.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24 | 285.00K shares derived: sum of 2 quarters · filed 2026-09-24 | 1.77M shares derived: sum of 3 quarters · filed 2026-09-24 | 2.51M shares 10-K · filed 2026-09-24 | |||||
| 2026-03-31 | 25.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | 1.51M shares derived: sum of 2 quarters · filed 2026-05-12 | 2.25M shares 10-Q · filed 2026-05-12 | 2.95M shares derived: sum of 4 quarters · filed 2026-09-24 | |||||
| 2025-12-31 | 1.48M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | 2.22M shares 10-Q · filed 2026-02-12 | 2.93M shares derived: sum of 3 quarters · filed 2026-09-24 | 4.77M shares derived: sum of 4 quarters · filed 2026-09-24 | |||||
| 2025-09-30 | 740.00K shares 10-Q · filed 2025-11-06 | 1.45M shares derived: sum of 2 quarters · filed 2026-09-24 | 3.29M shares derived: sum of 3 quarters · filed 2026-09-24 | 3.75M shares derived: sum of 4 quarters · filed 2026-09-24 | |||||
| 2025-06-30 | 705.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24 | 2.55M shares derived: sum of 2 quarters · filed 2026-09-24 | 3.01M shares derived: sum of 3 quarters · filed 2026-09-24 | 3.25M shares 10-K · filed 2026-09-24 | |||||
| 2025-03-31 | 1.84M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | 2.30M shares derived: sum of 2 quarters · filed 2025-05-13 | 2.54M shares 10-Q · filed 2025-05-13 | 2.70M shares derived: sum of 4 quarters · filed 2025-09-17 | |||||
| 2024-12-31 | 460.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | 700.00K shares 10-Q · filed 2025-02-12 | 859.50K shares derived: sum of 3 quarters · filed 2025-09-17 | 2.87M shares derived: sum of 4 quarters · filed 2025-09-17 | |||||
| 2024-09-30 | 240.00K shares 10-Q · filed 2024-11-07 | 399.50K shares derived: sum of 2 quarters · filed 2025-09-17 | 2.41M shares derived: sum of 3 quarters · filed 2025-09-17 | 2.47M shares derived: sum of 4 quarters · filed 2025-09-17 | |||||
| 2024-06-30 | 159.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | 2.17M shares derived: sum of 2 quarters · filed 2025-09-17 | 2.23M shares derived: sum of 3 quarters · filed 2025-09-17 | 2.64M shares 10-K · filed 2025-09-17 | 2.64M shares 10-K · filed 2024-09-19 | ||||
| 2024-03-31 | 2.01M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | 2.07M shares derived: sum of 2 quarters · filed 2024-05-15 | 2.48M shares 10-Q · filed 2024-05-15 | 2.55M shares derived: sum of 4 quarters · filed 2024-09-19 | |||||
| 2023-12-31 | 60.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | 475.00K shares 10-Q · filed 2024-02-13 | 547.00K shares derived: sum of 3 quarters · filed 2024-09-19 | 927.00K shares derived: sum of 4 quarters · filed 2024-09-19 | |||||
| 2023-09-30 | 415.00K shares 10-Q · filed 2023-11-13 | 487.00K shares derived: sum of 2 quarters · filed 2024-09-19 | 867.00K shares derived: sum of 3 quarters · filed 2024-09-19 | 1.05M shares derived: sum of 4 quarters · filed 2024-09-19 | |||||
| 2023-06-30 | 72.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | 452.00K shares derived: sum of 2 quarters · filed 2024-09-19 | 640.00K shares derived: sum of 3 quarters · filed 2024-09-19 | 740.00K shares 10-K · filed 2024-09-19 | 700.00K shares 10-K · filed 2023-09-14 | ||||
| 2023-03-31 | 380.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | 568.00K shares derived: sum of 2 quarters · filed 2023-05-11 | 668.00K shares 10-Q · filed 2023-05-11 | 7.65M shares derived: sum of 4 quarters · filed 2023-09-14 | |||||
| 2022-12-31 | 188.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | 288.00K shares 10-Q · filed 2023-02-10 | 7.27M shares derived: sum of 3 quarters · filed 2023-09-14 | 7.58M shares derived: sum of 4 quarters · filed 2023-09-14 | |||||
| 2022-09-30 | 100.00K shares 10-Q · filed 2022-11-09 | 7.08M shares derived: sum of 2 quarters · filed 2023-09-14 | 7.39M shares derived: sum of 3 quarters · filed 2023-09-14 | 7.42M shares derived: sum of 4 quarters · filed 2023-09-14 | |||||
| 2022-06-30 | 6.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-14 | 7.29M shares derived: sum of 2 quarters · filed 2023-09-14 | 7.33M shares derived: sum of 3 quarters · filed 2023-09-14 | 7.40M shares 10-K · filed 2023-09-14 | |||||
| 2022-03-31 | 312.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12 | 346.00K shares derived: sum of 2 quarters · filed 2022-05-12 | 421.00K shares 10-Q · filed 2022-05-12 | ||||||
| 2021-12-31 | 34.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | 109.00K shares 10-Q · filed 2022-02-09 | |||||||
| 2021-09-30 | 75.00K shares 10-Q · filed 2021-11-12 | ||||||||
| 2021-06-30 | 700.00K shares 10-K · filed 2022-09-15 | ||||||||
| 2021-06-14 | 700.00K shares 10-K · filed 2021-09-15 | ||||||||
| 2019-12-31 | 2.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-12 | 35.95M shares 10-Q · filed 2020-02-12 | 34.82M shares derived: sum of 3 quarters · filed 2020-02-12 | 34.82M shares derived: sum of 4 quarters · filed 2020-02-12 | |||||
| 2019-11-30 | 67.00M shares 10-Q · filed 2020-05-14 | ||||||||
| 2019-09-30 | 33.95M shares 10-Q · filed 2019-11-14 | 32.83M shares derived: sum of 2 quarters · filed 2019-11-14 | 32.83M shares derived: sum of 3 quarters · filed 2019-11-14 | 32.83M shares derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2019-07-31 | 679.00K shares 10-K · filed 2020-10-13 | 34.00M shares 10-Q · filed 2019-11-14 | |||||||
| 2019-06-30 | -1.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-10 | -1.12M shares derived: sum of 2 quarters · filed 2019-09-10 | -1.12M shares derived: sum of 3 quarters · filed 2019-09-10 | 1.13K shares 10-K · filed 2019-09-10 | |||||
| 2019-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | 0.00 shares derived: sum of 2 quarters · filed 2019-05-10 | 1.13M shares 10-Q · filed 2019-05-10 | 870.25K shares derived: sum of 4 quarters · filed 2019-09-10 | |||||
| 2018-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | 1.13M shares 10-Q · filed 2019-02-14 | 870.25K shares derived: sum of 3 quarters · filed 2019-09-10 | 870.25K shares derived: sum of 4 quarters · filed 2019-09-10 | |||||
| 2018-09-30 | 1.13M shares 10-Q · filed 2018-12-14 | 870.25K shares derived: sum of 2 quarters · filed 2019-09-10 | 870.25K shares derived: sum of 3 quarters · filed 2019-09-10 | 990.25K shares derived: sum of 4 quarters · filed 2019-09-10 | |||||
| 2018-06-30 | -254.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-10 | -254.75K shares derived: sum of 2 quarters · filed 2019-09-10 | -134.75K shares derived: sum of 3 quarters · filed 2019-09-10 | 255.00 shares 10-K · filed 2019-09-10 | 255.00K shares 10-K · filed 2018-10-15 | ||||
| 2018-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | 120.00K shares derived: sum of 2 quarters · filed 2018-05-15 | 255.00K shares 10-Q · filed 2018-05-15 | ||||||
| 2017-12-31 | 120.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | 255.00K shares 10-Q · filed 2018-02-14 | |||||||
| 2017-09-30 | 135.00K shares 10-Q · filed 2017-11-14 | ||||||||
| 2017-06-30 | 24.73M shares 10-K · filed 2018-10-15 | ||||||||
| 2016-06-30 | 285.00K shares 10-K · filed 2017-09-22 | ||||||||
| 2014-06-30 | 155.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | 2.83M shares 10-K · filed 2014-09-30 | |||||||
| 2014-03-31 | 2.68M shares 10-Q · filed 2014-05-14 | ||||||||
| 2013-09-30 | 9.05M shares 10-Q · filed 2013-11-12 | 1.56M shares derived: sum of 2 quarters · filed 2014-09-30 | |||||||
| 2013-06-30 | 8.33K shares 10-Q · filed 2014-05-14 | 50.00K shares 10-K · filed 2013-09-11 | -7.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | 1.51M shares 10-K · filed 2014-09-30 | 9.05M shares 10-K · filed 2013-09-11 | ||||
| 2013-03-31 | 9.00M shares 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |